ZMYND11

Zinc finger, MYND-type containing 11
Available structures
PDB Ortholog search: PDBe, RCSB
Identifiers
Symbols ZMYND11 ; BRAM1; BS69; MRD30
External IDs OMIM: 608668 MGI: 1913755 HomoloGene: 4828 IUPHAR: 2782 GeneCards: ZMYND11 Gene
RNA expression pattern
More reference expression data
Orthologs
Species Human Mouse
Entrez 10771 66505
Ensembl ENSG00000015171 ENSMUSG00000021156
UniProt Q15326 Q8R5C8
RefSeq (mRNA) NM_001202464 NM_001199141
RefSeq (protein) NP_001189393 NP_001186070
Location (UCSC) Chr 10:
0.13 – 0.25 Mb		 Chr 13:
9.68 – 9.77 Mb
PubMed search

Zinc finger MYND domain-containing protein 11 is a protein that in humans is encoded by the ZMYND11 gene.[1][2][3]

Function

The protein encoded by this gene was first identified by its ability to bind the adenovirus E1A protein. The protein localizes to the nucleus. It functions as a transcriptional repressor, and expression of E1A inhibits this repression. Alternatively spliced transcript variants encoding different isoforms have been identified.[3]

Interactions

ZMYND11 has been shown to interact with:

References

  1. ↑ Hateboer G, Gennissen A, Ramos YF, Kerkhoven RM, Sonntag-Buck V, Stunnenberg HG, Bernards R (Jul 1995). "BS69, a novel adenovirus E1A-associated protein that inhibits E1A transactivation". The EMBO Journal 14 (13): 3159–69. PMC 394377. PMID 7621829.
  2. ↑ Masselink H, Bernards R (Mar 2000). "The adenovirus E1A binding protein BS69 is a corepressor of transcription through recruitment of N-CoR". Oncogene 19 (12): 1538–46. doi:10.1038/sj.onc.1203421. PMID 10734313.
  3. 1 2 "Entrez Gene: ZMYND11 zinc finger, MYND domain containing 11".
  4. 1 2 Kurozumi K, Nishita M, Yamaguchi K, Fujita T, Ueno N, Shibuya H (Apr 1998). "BRAM1, a BMP receptor-associated molecule involved in BMP signalling". Genes to Cells 3 (4): 257–64. doi:10.1046/j.1365-2443.1998.00186.x. PMID 9663660.
  5. ↑ Hughes-Davies L, Huntsman D, Ruas M, Fuks F, Bye J, Chin SF, Milner J, Brown LA, Hsu F, Gilks B, Nielsen T, Schulzer M, Chia S, Ragaz J, Cahn A, Linger L, Ozdag H, Cattaneo E, Jordanova ES, Schuuring E, Yu DS, Venkitaraman A, Ponder B, Doherty A, Aparicio S, Bentley D, Theillet C, Ponting CP, Caldas C, Kouzarides T (Nov 2003). "EMSY links the BRCA2 pathway to sporadic breast and ovarian cancer". Cell 115 (5): 523–35. doi:10.1016/s0092-8674(03)00930-9. PMID 14651845.
  6. ↑ Wei G, Schaffner AE, Baker KM, Mansky KC, Ostrowski MC. "Ets-2 interacts with co-repressor BS69 to repress target gene expression". Anticancer Research 23 (3A): 2173–8. PMID 12894593.

Further reading

  • Bonaldo MF, Lennon G, Soares MB (Sep 1996). "Normalization and subtraction: two approaches to facilitate gene discovery". Genome Research 6 (9): 791–806. doi:10.1101/gr.6.9.791. PMID 8889548. 
  • Kurozumi K, Nishita M, Yamaguchi K, Fujita T, Ueno N, Shibuya H (Apr 1998). "BRAM1, a BMP receptor-associated molecule involved in BMP signalling". Genes to Cells 3 (4): 257–64. doi:10.1046/j.1365-2443.1998.00186.x. PMID 9663660. 
  • Lo KW, Naisbitt S, Fan JS, Sheng M, Zhang M (Apr 2001). "The 8-kDa dynein light chain binds to its targets via a conserved (K/R)XTQT motif". The Journal of Biological Chemistry 276 (17): 14059–66. doi:10.1074/jbc.M010320200. PMID 11148209. 
  • Ansieau S, Leutz A (Feb 2002). "The conserved Mynd domain of BS69 binds cellular and oncoviral proteins through a common PXLXP motif". The Journal of Biological Chemistry 277 (7): 4906–10. doi:10.1074/jbc.M110078200. PMID 11733528. 
  • Wei G, Schaffner AE, Baker KM, Mansky KC, Ostrowski MC (2003). "Ets-2 interacts with co-repressor BS69 to repress target gene expression". Anticancer Research 23 (3A): 2173–8. PMID 12894593. 
  • Hughes-Davies L, Huntsman D, Ruas M, Fuks F, Bye J, Chin SF, Milner J, Brown LA, Hsu F, Gilks B, Nielsen T, Schulzer M, Chia S, Ragaz J, Cahn A, Linger L, Ozdag H, Cattaneo E, Jordanova ES, Schuuring E, Yu DS, Venkitaraman A, Ponder B, Doherty A, Aparicio S, Bentley D, Theillet C, Ponting CP, Caldas C, Kouzarides T (Nov 2003). "EMSY links the BRCA2 pathway to sporadic breast and ovarian cancer". Cell 115 (5): 523–35. doi:10.1016/S0092-8674(03)00930-9. PMID 14651845. 
  • Colland F, Jacq X, Trouplin V, Mougin C, Groizeleau C, Hamburger A, Meil A, Wojcik J, Legrain P, Gauthier JM (Jul 2004). "Functional proteomics mapping of a human signaling pathway". Genome Research 14 (7): 1324–32. doi:10.1101/gr.2334104. PMC 442148. PMID 15231748. 
  • Rual JF, Venkatesan K, Hao T, Hirozane-Kishikawa T, Dricot A, Li N, Berriz GF, Gibbons FD, Dreze M, Ayivi-Guedehoussou N, Klitgord N, Simon C, Boxem M, Milstein S, Rosenberg J, Goldberg DS, Zhang LV, Wong SL, Franklin G, Li S, Albala JS, Lim J, Fraughton C, Llamosas E, Cevik S, Bex C, Lamesch P, Sikorski RS, Vandenhaute J, Zoghbi HY, Smolyar A, Bosak S, Sequerra R, Doucette-Stamm L, Cusick ME, Hill DE, Roth FP, Vidal M (Oct 2005). "Towards a proteome-scale map of the human protein-protein interaction network". Nature 437 (7062): 1173–8. doi:10.1038/nature04209. PMID 16189514. 
  • Isobe T, Uchida C, Hattori T, Kitagawa K, Oda T, Kitagawa M (Jan 2006). "Ubiquitin-dependent degradation of adenovirus E1A protein is inhibited by BS69". Biochemical and Biophysical Research Communications 339 (1): 367–74. doi:10.1016/j.bbrc.2005.11.028. PMID 16300738. 
  • Wan J, Zhang W, Wu L, Bai T, Zhang M, Lo KW, Chui YL, Cui Y, Tao Q, Yamamoto M, Akira S, Wu Z (Jan 2006). "BS69, a specific adaptor in the latent membrane protein 1-mediated c-Jun N-terminal kinase pathway". Molecular and Cellular Biology 26 (2): 448–56. doi:10.1128/MCB.26.2.448-456.2006. PMC 1346911. PMID 16382137. 
  • Velasco G, Grkovic S, Ansieau S (Jun 2006). "New insights into BS69 functions". The Journal of Biological Chemistry 281 (24): 16546–50. doi:10.1074/jbc.M600573200. PMID 16565076. 


This article is issued from Wikipedia - version of the Sunday, August 02, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.